Treatment Options for Meniere's Disease
The treatment of Meniere's disease should follow a stepwise approach, starting with lifestyle modifications and progressing to pharmacotherapy, intratympanic therapies, and surgical interventions only when necessary. 1
First-Line Treatments: Lifestyle and Dietary Modifications
- Restrict sodium intake to 1500-2300 mg daily to reduce fluid accumulation in the inner ear 1
- Limit alcohol consumption as it can trigger attacks in susceptible patients 1
- Reduce caffeine intake which may act as a symptom trigger 1
- Identify and manage allergies, which may contribute to symptoms in up to 30% of patients 1
- Implement stress management techniques including relaxation, regular exercise, and adequate sleep 1
- Maintain a symptom diary to identify personal triggers 1
Acute Attack Management
- Offer short-term vestibular suppressants only during acute vertigo attacks 1
- Use antihistamines such as dimenhidrinato or meclizine for symptomatic relief 1
- Consider benzodiazepines for associated anxiety, but use cautiously due to dependency risk 1
Maintenance Pharmacotherapy
- Diuretics are recommended to alter electrolyte balance in the endolymph and reduce its volume 1
- Betahistine's efficacy is questionable based on recent evidence:
- The 2020 American Academy of Otolaryngology-Head and Neck Surgery guideline cannot make a definitive recommendation for betahistine 2, 3
- The BEMED trial found no significant difference between betahistine (at either low 48 mg/day or high 144 mg/day doses) and placebo in reducing vertigo attacks 2, 3
- If prescribed, monitor for side effects including headache, nausea, and gastrointestinal symptoms 3
- Contraindicated in patients with pheochromocytoma and should be used cautiously in those with asthma or peptic ulcer disease 3
Intratympanic Therapies
Intratympanic steroids may be offered to patients with active Meniere's disease not responsive to non-invasive treatments 2
Intratympanic gentamicin is effective for vertigo control in patients who have failed conservative therapies 2
- Complete vertigo control rate of approximately 73.6% across studies 2
- Titration therapy showed better control (81.7%) compared to low-dose methods (66.7%) 2
- Risk of hearing loss varies by administration method: weekly titration (13.1%), multiple daily dosing (34.7%), with overall average of 25.1% 2
- Profound hearing loss occurs in approximately 6.6% of cases regardless of delivery method 2
- Contraindicated in patients with bilateral disease or vestibular hypofunction 2
Surgical Options
- Labyrinthectomy may be offered to patients with active Meniere's disease who have failed less definitive therapy and have non-usable hearing 2
- Surgical interventions should be considered only after failure of medical management 1, 4
Treatments Not Recommended
- Positive pressure therapy (Meniett device) is not recommended based on systematic reviews showing no significant difference compared to placebo 2, 1
- Vestibular rehabilitation is not recommended for acute attacks but may help with chronic imbalance between episodes 1
Important Considerations
- No definitive cure exists for Meniere's disease 1
- Treatment efficacy should be monitored through documentation of symptom changes and quality of life impact 1
- Bilateral involvement occurs in 25-40% of cases, which may affect treatment decisions, particularly regarding ablative therapies 4
- Without treatment, hearing may deteriorate over 10+ years as vertiginous episodes gradually subside 5